Literature DB >> 30026017

Increased rates of 25-hydroxy vitamin D testing: Dissecting a modern epidemic.

Celia Rodd1, AbdulRazaq Sokoro2, Lisa M Lix3, Laurel Thorlacius4, Michael Moffatt5, Jim Slater6, Eric Bohm7.   

Abstract

INTRODUCTION: Laboratories have noted marked increases in the analysis of 25-hydroxy vitamin D (25(OH)D) in recent decades. Our objectives were to describe the annual number of 25(OH)D tests, examine the characteristics of those tested and those ordering them, and determine the proportion of potentially unnecessary tests in Manitoba.
METHODS: Manitoba residents who were tested between 2006/7 and 2012/13 had their data anonymously linked to Manitoba Centre for Health Policy comprehensive administrative datasets. Patient and physician characteristics, location of residence, and 25(OH)D concentrations were determined. Descriptive statistics and multivariable regression models were utilized.
RESULTS: There was a quadrupling in testing from 2006 to 2013, with >20,000 tests performed in 2012/13. The median annual number of tests was one per patient; the maximum was >10 tests per year. Adult females had twice the number of tests compared to males (p < 0.001). There was a rise in 25(OH)D concentrations over time with hypervitaminosis D increasing disproportionately (2006/7 to 212/13 (0% vs. 0.15%, p < 0.001)). Apparently unnecessary testing rose by 1/3 over time, frequently ordered by Family Medicine practitioners. A revised 25(OH)D requisition resulted in striking reduction of 25(OH)D requests (~80%). DISCUSSION: Manitoba noted a rapid increase in testing, and rise in 25(OH)D concentrations with levels that may be associated with toxicities; both have been reported in other jurisdictions. There appeared to a striking rise in 'unnecessary' tests. We similarly report the benefit of the implementation of a mandatory requisition specifying eligibility criteria for 25(OH)D and education about appropriate testing.
Copyright © 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  25-hydroxy vitamin D; Client characteristics; Family physician; Specialist; Unnecessary testing; Vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30026017     DOI: 10.1016/j.clinbiochem.2018.07.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Regulation of calcific vascular and valvular disease by nuclear receptors.

Authors:  Tamer Sallam; Yin Tintut; Linda L Demer
Journal:  Curr Opin Lipidol       Date:  2019-10       Impact factor: 4.776

2.  Is the Climb Worth the View? The Savings/Alert Ratio for Reducing Vitamin D Testing.

Authors:  Chase D Hendrickson; Michael F McLemore; Kathryn M Dahir; Shari Just; Zahra Shajani-Yi; Joseph LeGrand; Christoph U Lehmann; Asli Weitkamp
Journal:  Appl Clin Inform       Date:  2020-02-26       Impact factor: 2.342

3.  Trends in Micronutrient Laboratory Testing in Switzerland: A 7-Year Retrospective Analysis of Healthcare Claims Data.

Authors:  Carola A Huber; Michael Nagler; Thomas Rosemann; Eva Blozik; Markus Näpflin; Stefan Markun
Journal:  Int J Gen Med       Date:  2020-12-02

Review 4.  Health, financial and environmental impacts of unnecessary vitamin D testing: a triple bottom line assessment adapted for healthcare.

Authors:  Matilde Breth-Petersen; Katy Bell; Kristen Pickles; Forbes McGain; Scott McAlister; Alexandra Barratt
Journal:  BMJ Open       Date:  2022-08-23       Impact factor: 3.006

5.  Stable Rates of Low Vitamin D Status Among Children Despite Increased Testing: A Population-Based Study.

Authors:  Alyssa A Kerber; Mitchell M Pitlick; Anna E Kellund; Amy L Weaver; Seema Kumar; Avni Y Joshi
Journal:  J Pediatr       Date:  2021-07-20       Impact factor: 6.314

6.  Reducing overutilisation of serum vitamin D testing at a tertiary care centre.

Authors:  Felicia Tai; Ian Chin-Yee; Alan Gob; Vipin Bhayana; Angela Rutledge
Journal:  BMJ Open Qual       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.